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Abstract    30 
 31 
Background: This study aimed to explore the association between depression and body mass 32 
index (BMI), and to investigate whether genetic susceptibility to high BMI is different among 33 
individuals with or without depression.  34 
Methods: We used data on 251,125 individuals of white British ancestry from the UK 35 
Biobank. We conducted Mendelian randomisation (MR) analysis to test for a causal 36 
association between depression and BMI using a major depressive disorder (MDD)-related 37 
genetic risk score (GRSMDD) as an instrument for depression. We also examined whether 38 
depression modifies genetic susceptibility to high BMI, by investigating the interaction 39 
between depression and the BMI-related genetic risk score (GRSBMI).  40 
Results: We found observational and genetic evidence for an association between depression 41 
and BMI (MR beta: 0.09, 95% CI 0.04-0.13). Further, the contribution of genetic risk to high 42 
BMI was higher among individuals with depression compared to controls. Carrying ten 43 
additional BMI increasing alleles was associated with 0.24 SD (95% CI 0.23-0.25) higher 44 
BMI among depressed individuals compared to 0.20 SD (95% CI 0.19-0.21) higher in 45 
controls, which corresponds to 3.4 kg and 2.8 kg extra weight for an individual of average 46 
height. Amongst the individual loci, the evidence for interaction was most notable for a 47 
variant near MC4R, a gene known to affect both appetite regulation and the hypothalamic 48 
pituitary adrenal axis (Pinteraction=5.7 x 10
-5). Conclusion: Genetic predisposition to high BMI 49 
was higher among depressed than to non-depressed individuals. This study provides support 50 




Key words: “gene-lifestyle factors interaction”, “genetic risk score”, “MC4R”, “depression”, 53 
“BMI”, “predisposition”, and “UK-Biobank”. 54 
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Introduction  56 
 57 
The obesity epidemic is worsening globally, with prevalence tripling over the last three 58 
decades (Afshin et al., 2017). From 1980 to 2015, excess fat accumulation contributed to an 59 
estimated 4 million deaths through its association with cardiovascular, metabolic, cancer and 60 
other diseases, leading to a loss of 120 million disability-adjusted life years (Afshin et al., 61 
2017). An obesogenic environment, characterised by sedentary behaviour and abundance of 62 
energy-rich food, is among a very large number of potential contributors to high body mass 63 
index (BMI) at the population level (Townshend & Lake, 2017). However, genetic factors are 64 
also a known to affect BMI (Locke et al., 2015; Zaitlen et al., 2013), and heritability studies 65 
have indicated that 40-70% of BMI variability can be  attributed to genetic factors (Zaitlen et 66 
al., 2013). Genome-wide association studies (GWAS) have identified over 700 BMI related 67 
genetic variants, which only explain 5% of the variability in BMI (Yengo et al., 2018). Some 68 
of this missing heritability of BMI could be explained by an interaction between these genetic 69 
variants and lifestyle factors.   70 
 71 
Previous interaction studies on BMI-related genetic variants and lifestyle factors highlight the 72 
importance of modifying diet and physical activity to decrease high BMI risk in genetically 73 
predisposed individuals (Celis-Morales et al., 2016; Vimaleswaran et al., 2016). Another 74 
possible factor that may modify genetic susceptibility to high BMI is comorbid depression. 75 
Prior research has demonstrated that depressed individuals tend to lead more sedentary 76 
lifestyles, be less physically active and have worse dietary habits, each of which may 77 
contribute to high BMI (Jacka, Cherbuin, Anstey, & Butterworth, 2014; Roshanaei-78 
Moghaddam, Katon, & Russo, 2009). There is evidence that obesity is a causal risk factor for 79 
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depression (Tyrrell J et al., 2018), and prospective observational evidence that depression 80 
itself may lead to obesity (Mannan, Mamun, Doi, & Clavarino, 2016).  81 
 82 
Recent success in identifying genetic variants affecting susceptibility to major depressive 83 
disorder (MDD) (Wray et al., 2018), enables the use of Mendelian randomization (MR) for 84 
testing the causal association between depression and BMI. Compared to traditional 85 
observational approaches, MR studies are less prone to bias by confounding or reverse 86 
causation (Zheng et al., 2017). To our knowledge there are no earlier MR studies examining 87 
the causal effect of depression on BMI, and only a few studies have investigated whether 88 
depression influences genetic susceptibility to high BMI (Hung et al., 2014; Rivera et al., 89 
2012). 90 
 91 
In this study we have used information from 251,125 UK Biobank participants to investigate 92 
the observational and genetic associations between depression and BMI, and to test whether 93 
genetic susceptibility to high BMI is modified by the presence of depression. To explore this 94 
relationship further, we performed secondary analyses according to biological pathway-based 95 
genetic risk score of BMI (GRSBMI), and using each genetic variant individually in the 96 
interaction tests.   97 
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Methods  98 
 99 
The UK Biobank is a population-based cohort of over 500 000 individuals (age ranging 37 to 100 
73 years old at recruitment) living in the United Kingdom (Allen et al., 2012) (Supplementary 101 
Methods). We used information on 251 125 individuals of white British ancestry (as 102 
evidenced by self-report and genetic ancestry analyses) who have complete data on 103 
genotypes, BMI and depression status. Related individuals, and those with a mismatch 104 
between self-reported and genetically determined sex, and/or who have failed genotype and 105 
imputation quality control (Bycroft et al., 2018), were excluded from the analyses.  106 
Measured weight (kg) and height (m) were used to derive BMI (kg/m2). Individuals with a 107 
BMI greater than or equal to 30kg/m2 were classified as obese (WHO, 2016). For analysis, 108 
BMI was inverse normal transformed, with one SD corresponding to 4.74 kg/m2. Secondary 109 
analysis used alternate measures of adiposity, including waist circumference (WC) and body 110 
fat percentage (BFP) (Supplementary Methods).  Lifestyle and socioeconomic information 111 
was self-reported, and derived from the baseline assessment (Sudlow et al., 2015) 112 
(Supplementary Methods).   113 
 114 
We used depression-related information from touchscreen questionnaires, nurse-led 115 
interviews, and hospital-linked data to classify depression cases, and to identify controls 116 
(Sudlow et al., 2015). Participants who had seen a general practitioner or a psychiatrist for 117 
anxiety, tension, nervousness or depression, and reported depression or unenthusiasm of at 118 
least two weeks duration were recoded as having depression. Additional cases were identified 119 
from hospital diagnoses (ICD-10 F32 or F33 or the corresponding ICD-9 codes) obtained 120 




Individuals in the control group were those who had not seen a general practitioner or 123 
psychiatrist for anxiety, tension, nervousness or depression, and who had no hospital 124 
diagnosed depression, and no self-reported depression. For further sensitivity analysis, we 125 
categorized depression into single episode depressive disorder and recurrent depressive 126 
disorder depending the number of depressive episodes; and used the HES data defined 127 
depression variables as alternative outcomes.    128 
 129 
Genetic variants and genetic risk score  130 
To investigate the causal association between depression and BMI, we used 44 MDD related 131 
genetic variants (Supplementary table 1) identified in a recent genome-wide association 132 
meta-analysis which included 135,458 MDD cases and 344,901 controls (Wray et al., 2018). 133 
To test for an interaction between depression and BMI-related genetic risk, we selected BMI 134 
increasing variants from the largest GWAS meta-analysis (N=339 224) which did not include 135 
the UK Biobank (Locke et al., 2015). This study included 339 224 individuals and identified 136 
97 BMI increasing variants (Locke et al., 2015). Among these, 77 variants were identified in 137 
European ancestry sex-combined analysis, of which rs7903146 (TCF7L2) is a primary variant 138 
for type 2 diabetes, and hence was excluded from the current analyses. Three other variants 139 
were excluded because of their strong association with traits other than BMI (horizontal 140 
pleiotropy). These included rs11030104 (reward phenotype), rs13107325 (HDL level and 141 
blood pressure), and rs3888190 (multiple traits) (MacArthur et al., 2017). Subsequently our 142 




Based on the number of risk alleles associated with depression or BMI, each genetic variant 145 
was coded as 0 (no risk alleles), 1 (one risk allele) and 2 (two risk alleles). We used an 146 
additive genetic model, and constructed a weighted GRS by summing the product of the 147 
number of risk-increasing alleles by each genetic variant’s weight taken from the primary 148 
GWAS (Locke et al., 2015; Wray et al., 2018). The weighted GRS was re-scaled using the 149 
formula below to express the change in effect size per number of risk increasing alleles (See 150 
the equation below).  151 
 152 
 153 
To investigate the biological mechanism of how depression modifies genetic susceptibility to 154 
high BMI, we grouped the 73 genetic variants as neuronal and non-neuronal, based on their 155 
proximity to genes enriched in the respective pathways (Locke et al., 2015). Locke et al 156 
manually reviewed literature for gene activity and function with respect to all 405 genes 157 
within 500kb and r2>0.2 from the 97 BMI-associated lead variants, resulting in classification 158 
of the variants into 25 biological categories including peripheral and central biological 159 
mechanisms (Locke et al., 2015). Forty-three of the 73 BMI-associated genes are expressed 160 
predominantly in the central nervous system (CNS), and are understood to affect neuronal 161 
development, neuronal and hypothalamus expression, and energy metabolism (Locke et al., 162 
2015). Accordingly, these were grouped as neuronal variants (Supplementary table 2). The 163 
Where:  





 is a coefficient from variant-exposure association of n variants taken from the 
GWAS discovery analyses, i.e. MDD GWAS (Wray et al., 2018) for genetic score of 





remaining 30 BMI-related variants were hypothesized to affect BMI through processes other 164 
than the CNS (Locke et al., 2015), and were subsequently classified as non-neuronal. GRSBMI 165 
for neuronal and non-neuronal variants were constructed. A third GRSBMI (termed ‘total’) 166 
was also constructed incorporating all 73 BMI related genetic variants.   167 
 168 
Statistical analysis  169 
Our depression to BMI association analysis comprised linear regression on BMI, with 170 
adjustment first for age, sex and assessment centre, then further adjustment for broader 171 
covariates including Townsend deprivation index, education, physical activity, sedentary 172 
behaviour, vegetable and fruit consumption, cigarette smoking, alcohol consumption and 173 
general health status. This was followed by one-sample MR analysis using two-stage least 174 
squares regression to establish evidence for a causal relationship between depression and 175 
BMI. The genetic analysis further adjusted for genotyping array and 15 principal 176 
components. Sensitivity analyses used two-sample MR with complementary approaches 177 
including inverse-variance weight (MR IVW), weighted median, and MR-Egger methods 178 
(Supplementary Methods). 179 
   180 
In depression by variant interaction analysis, we first checked the association of the GRSBMI 181 
and each genetic variant with BMI using linear regression. To test for the interaction between 182 
total GRSBMI and depression on BMI, we included an interaction term in the linear regression 183 
model. We repeated the test using pathway-specific GRSBMI, and also performed interaction 184 
tests for each BMI-related genetic variant. All analyses were adjusted for age, sex, 185 
assessment centre, type of genotyping array, 15 principal components, and socioeconomic 186 
and lifestyle factors including Townsend deprivation index, education, physical activity, 187 
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sedentary behaviour, vegetable and fruit consumption, cigarette smoking, alcohol 188 
consumption and general health status.   189 
 190 
To check whether any significant interactions were also seen with other measures of 191 
adiposity, we repeated the analyses using inverse normal transformed WC, and BFP as 192 
outcomes in a linear regression model. Logistic regression was used to test the interaction 193 
with respect to obesity. Upon a significant interaction, we stratified the association between 194 
GRSBMI and BMI by depression status. For statistical significance, we used P-value threshold 195 
of 0.05 for tests involving total GRSBMI. Analyses involving multiple testing used a 196 
Bonferroni corrected p-value to minimise the likelihood of a false-positive result. Bonferroni 197 
corrected significant thresholds of 0.025 (i.e. 0.05/2) and 0.0007 (i.e. 0.05/73) were used for 198 
the pathway-based GRS’, and single variant analyses respectively. 199 
 200 
Sensitivity analyses were also completed using by severity of depression, as follows: single 201 
episode, recurrent depressive disorder, and any hospital diagnosed depression based on HES 202 
data. To clarify whether the interaction was driven by only a few genetic variants, we tested 203 
the hypothesis using a GRSBMI from which the variants observed to have significant 204 
interaction with depression had been omitted. To further clarify whether this interaction was 205 
due to concomitant use of antidepressants, we adjusted the models for current use of 206 
antidepressant medications.    207 
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Results  208 
 209 
Table 1 shows mean BMI and percentage of obesity of individuals stratified by lifestyle 210 
factors, depression status, and high BMI genetic load. Men were observed to have a higher 211 
mean BMI and obesity prevalence (P<4.9 x 10-57). Notably, prevalence of obesity was 212 
observed to increase with reducing levels of self-reported general health (P<1.0 x 10-300). 213 
Individuals who had a history of depression including single episode, recurrent depressive 214 
disorder, and hospital diagnosed depression all had higher mean BMIs and higher prevalence 215 
of obesity, than controls (P<4.9 x 10-78). Antidepressant medication use was also associated 216 
with BMI and obesity (P<3.0 x 10-285). The mean BMI and prevalence of obesity were higher 217 
in the 50% of people having more BMI genetic load compared with the 50% of people having 218 
low BMI genetic load (P<1.0 x 10-300).  219 
 220 
Observational and genetic evidence for association between depression and BMI  221 
In the phenotypic analysis, individuals with depression had 0.19 SD (95% CI 0.18 to 0.20, P 222 
= 5.0 x 10-215) higher BMIs compared to those without depression (Table 2). This association 223 
was supported by genetic evidence, and in MR analyses a higher genetic risk of depression 224 
was associated with higher BMI (OR 0.09 SD, 95% CI 0.04 to 0.13, P =0.0001). MR-IVW, 225 
weighted median, and MR-Egger estimates from two-sample MR were directionally 226 
consistent with estimates from one-sample MR, but with wider confidence intervals (Table 227 
2). MR-Egger intercept was not significantly different from zero (P=0.06) with no evidence 228 
for directional pleiotropy.   229 
 230 
Association between genetic variants and BMI  231 
13 
 
Each of the 73 BMI genetic variants explained 0.11% to 0.39% of the variability in BMI 232 
(Supplementary table 2). Among these variants, FTO gene, and MC4R gene were the two 233 
strongest influences on the variability in BMI (r2 of FTO=0.39%, r2 of MC4R =0.23%). The 234 
‘C’ allele of rs6567160 near MC4R is a risk-increasing allele for BMI and obesity and 235 
individuals with TC and CC genotypes had higher BMIs and obesity prevalence compared to 236 
homozygous T allele carriers (P<3.8 x 10-36, Table 1).The GRSBMI’ showed normal 237 
distribution and was associated with high BMI (Figure 1). Total GRSBMI (including 73 238 
genetic variants) explained 1.3% of the variability in BMI, neuronal GRSBMI (including 43 239 
genetic variants) explained 0.94% of the variability, and the non-neuronal GRSBMI explained 240 
0.40% of the variability (Table 3). The contribution of GRSBMI’ or a variant near the MC4R 241 
gene on BMI was different between men and women (Pinteraction<0.01, Table 3). In the 242 
analyses using the GRSBMI’ and for MC4R, women had a greater increase in BMI compared 243 
to men for every increase in risk allele (Table 3).  244 
 245 
Genetic contribution to BMI is modified by depression status  246 
Depression modified the association of genetic variants with BMI (Table 4). Genetic 247 
susceptibility to BMI was higher in depressed individuals compared to non-depressed 248 
individuals (Pinteraction=9.1 x 10
-4), and carrying ten additional risk alleles was associated with 249 
0.24 SD, (95% CI 0.23 to 0.25) and 0.20 SD (95% CI 0.19 to 0.21) higher BMI among 250 
depressed and non-depressed individuals. Here, one SD represents 4.72 kg/m2 difference in 251 
BMIs hence,  these data are equivalent 3.4 kg and 2.8 kg extra weight for 1.73 m tall average 252 
depressed and non-depressed individual, respectively. This interaction was also observed 253 
when using WC or BFP as an outcome (Pinteraction<0.004), but not with obesity 254 




We next compared the association between depression and BMI with respect to effect 257 
modification by pathway-specific GRSBMI (neuronal vs. non-neuronal). Statistical evidence 258 
for interaction by depression in the genetic contribution to BMI was seen for neuronal 259 
pathway-related genetic variants, but not for non-neuronal pathway variants (neuronal 260 
GRSBMI Pinteraction=0.009, non-neuronal GRS Pinteraction=0.10). However, differences in the 261 
estimated effect sizes were negligible (Figure 2 and Supplementary figure 2).    262 
 263 
To check whether the interaction was driven by a particular genetic variant, each variant was 264 
tested for interaction with depression. Before correction for multiple testing there were seven 265 
variants showing evidence of interaction at P<0.05, but none of the associations remained 266 
after Bonferroni-correction, with a suggestive interaction coming only from rs6567160 near 267 
MC4R gene (Pinteraction=2.3 x 10
-3, Supplementary table 4).  268 
 269 
In sensitivity analysis restricted the depression outcome to HES data, the interaction between 270 
depression and total GRSBMI remained significant (Pinteraction=6.8 x 10
-4, Supplementary table 271 
5). This interaction was predominately driven by neuronal pathway specific variants, as was 272 
the case with our main finding (neuronal GRSBMI Pinteraction=2.9 x 10
-4, non-neuronal GRSBMI 273 
Pinteraction=0.47, Supplementary table 5). Specifically, rs6567160 was observed to be 274 
influential (Pinteraction=5.7 x 10
-5, Figure 3). Having ten additional neuronal-specific BMI risk 275 
alleles was associated with 0.21 SD (95%CI 0.20 to 0.23) higher BMI in non-depressed 276 
individuals, compared to 0.29 SD, (95%CI 0.24 to 0.34) in depressed individuals 277 
(Supplementary table 5). For the non-neuronal GRSBMI, the ten additional BMI risk alleles 278 
were associated with a 0.20 SD, (95%CI 0.19 to 0.22) and 0.24 SD, (95%CI 0.16 to 0.31) 279 
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higher BMI among individuals without and with depression, respectively. The risk allele (C) 280 
at MC4R variant rs6567160 contributed to 0.05 SD, (95%CI 0.04 to 0.06) and 0.11 SD, 281 
(95%CI 0.07 to 0.15) higher BMI in non-depressed and depressed individuals, respectively 282 
(Supplementary table 5).   283 
 284 
When looking at effect modification on the genetic influence on BMI by alternative 285 
depression classifications, evidence for interaction by single episode depressive disorder was 286 
seen for total GRSBMI (Pinteraction=0.004), neuronal GRSBMI (Pinteraction=0.003), and a variant 287 
near MC4R (Pinteraction=7 x 10
-5). No significant interactions were apparent for recurrent 288 
depressive disorder (for all, Pinteraction>0.15, Supplementary table 6). To understand whether 289 
the interaction between total GRSBMI and neuronal pathway specific GRSBMI with depression 290 
is solely contributed to by MC4R, we constructed a GRSBMI excluding rs6567160 (near 291 
MC4R). The interaction between depression and neuronal GRSBMI (Pinteraction=0.02) was only 292 
borderline significant at Bonferroni corrected p-value (P=0.025, Supplementary table 7), 293 
suggesting that the interaction is in part driven by a variant near the MC4R gene. For total 294 
GRSBMI, the interaction by depression was also attenuated by the absence of the variant 295 
nearby MC4R, again highlighting its influence (Supplementary table 7). Adjusting for 296 
recurrent use of antidepressant medication had a negligible influence on the interaction 297 
between GRSBMI and depression (Supplementary table 8).   298 
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Discussion  299 
Using 251 125 individuals of white British ancestry, we found observational and genetic 300 
evidence for an association between depression and BMI, and an increased genetic 301 
predisposition to higher BMI among individuals with depression compared to controls. 302 
Depression is known to have broad influences on an individual’s behaviour and lifestyles 303 
(Roshanaei-Moghaddam et al., 2009). There is also evidence to show that heritability of 304 
obesity is notably higher in obesogenic compared to non-obesogenic environments 305 
(Schrempft et al., 2018). Like obesogenic environments, depression may act to endorse 306 
unhealthy lifestyle choices, allowing the genetic potential for higher BMI to be expressed. 307 
While our study also suggested that the interaction between genetic predisposition to higher 308 
BMI and depression is likely to be most pronounced for variants implicated in neuronal 309 
pathways, potentially influencing behaviours (Locke et al., 2015), further studies are required 310 
to establish underlying mechanisms and patterns of mediation.  311 
 312 
As expected, the BMI-related GRS was associated with BMI. This association was more 313 
apparent in depressed individuals compared to non-depressed, and the total GRSBMI (73 314 
variants) explained 1.7% and 1.3% of the variability of BMI in individuals with and without 315 
hospital diagnosed depression, respectively. This finding is consistent with a previous study 316 
in which a GRS of 32 variants explained 1.6% of the variability in BMI among depressed 317 
individuals compared to 0.3% among non-depressed individuals (Hung et al., 2015). In 318 
keeping with our results, this prior study also noted a stronger association of their GRSBMI 319 
with BMI among depressed individuals when the depression outcome measure is derived 320 
from hospital episode statistics, than data collected from the general population (Hung et al., 321 




This study utilised BMI-associated variants from different biological pathways to explore the 324 
link between depression and high BMI. Although related differences between neuronal 325 
GRSBMI and non-neuronal GRSBMI were small, the evidence of an interaction from the 326 
former, suggests a role of the CNS in the link between depression and high BMI. Previous 327 
studies have indicated that the hypothalamic-pituitary-adrenal (HPA) axis is involved in the 328 
pathogenesis of depression and obesity (Bose, Olivan, & Laferrere, 2009; Varghese & 329 
Brown, 2001). This is supported further by our finding that rs6567160 near the MC4R gene 330 
was the main variant driving the interaction with depression on BMI. Interestingly 331 
rs17782313, which is in perfect LD with rs6567160, has previously been reported to interact 332 
with stress, and influence obesity risk (Park et al., 2016).The importance of the MCR4 gene 333 
in the depression-high BMI relationship is also evident in animal-based pharmacological 334 
studies, in which the antagonist of MCR4 receptor has shown anxiolytic and antidepressant 335 
effects, particularly under conditions of high stress (Chaki & Okubo, 2007). This antagonist 336 
was suggested for treatment of cachexia through the effect on increasing food intake, and 337 
decreasing energy expenditure (Weyermann et al., 2009).  338 
 339 
MC4R is found mainly in the CNS including the paraventricular nucleus of the hypothalamus, 340 
a centre involved in appetite and energy regulation, and HPA axis function (Chaki & Okubo, 341 
2007; Krashes, Lowell, & Garfield, 2016). Activation of the MC4R receptor in the 342 
hypothalamus has been associated with decreased appetite and food intake through 343 
stimulation of the satiety centre, and inhibition of the hunger centre (Krashes et al., 2016). 344 
Individuals with depression have stress-induced dysregulation of the HPA axis, a process that 345 
involves secretion of corticotrophin-releasing factor (CRF) from the hypothalamus (Chaki & 346 
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Okubo, 2007). Also, MC4R partly mediates secretion of CRF from corticotrophin neurons in 347 
the hypothalamus (Chaki & Okubo, 2007; Von Frijtag, Croiset, Gispen, Adan, & Wiegant, 348 
1998). We did not observe an independent association between MC4R and depression. This 349 
might suggests that the interaction between MC4R and depression on BMI may be due to a 350 
direct impact on appetite regulation – rather than depression associated activation of the HPA 351 
axis.  352 
 353 
Our study has some limitations. Firstly, UK Biobank participants are relatively healthy 354 
compared to the general population (Fry et al., 2012), which may limit the chance of 355 
detecting a robust gene-lifestyle interaction. As with other observational investigations, our 356 
gene-depression interaction study could have been affected by unmeasured confounding 357 
factors. However, to minimise such influence, our analyses included a wide range of lifestyle 358 
factors including the Townsend deprivation index, education, physical activity, sedentary 359 
behaviour, vegetable and fruit consumption, cigarette smoking, alcohol consumption, and 360 
general health status. We also conducted adjusted analyses to account for potential weight 361 
gain attributable to anti-depressant use; however, the observed interaction between 362 
depression and the genetic contribution to BMI remained unaffected.  363 
 364 
 Conclusions  365 
Our study provides genetic evidence for causal effect of depression on BMI. Furthermore, 366 
genetic predisposition to high BMI was increased among depressed compared to non-367 
depressed individuals, suggesting that depression might increases the expression of an 368 
individual’s genetic disposition to obesity. Our study provided some support for a possible 369 
role of MC4R in the link between depression and obesity. This result may strengthen the case 370 
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Tables  483 
Table 1. Mean BMI and the prevalence of obesity by participant characteristics in the UK 484 
Biobank 485 
  All, n (%) BMI†, mean (SD) Obesity‡, n (%) 
Sex    
Women  123 496 (49.97) 26.9 (5.1) 28 053 (22.4) 




Age (in years)    
39-45 29 649 (11.8) 26.8 (4.8) 6 015 (20.3) 
46-51 39 298 (15.7) 27.1 (4.8) 8 916 (22.7) 
52-57 47 624 (19.0) 27.4 (4.9) 11 691 (24.6) 
58-63 70 571 (28.1) 27.5 (4.6) 17 527 (24.8) 




Depression (self-reported + hospital 
diagnosed) 
   
Control 217 882 (86.8) 27.2 (4.5) 49 714 (22.8) 




Single episode depressive (F32)    
Control 217 882 (86.8) 27.2 (4.5) 49 714 (22.8) 




Recurrent depressive disorder (F33)    
Control 217 882 (86.8) 27.2 (4.5) 49 714 (22.8) 




Hospital diagnosed Depression    
Control  218 407 (96.4) 27.3 (4.6) 55 988 (23.2) 




Anti-depressant medication usage     
No  239 176 (95.2) 27.3 (4.6) 55 102 (23.0) 




BMI GRS (group using median)    
<65 125 573 (50.0) 26.9 (4.4) 25 487 (20.3) 




rs6567160 (MC4R)    
TT 146 965 (58.6) 27.3 (4.6) 33 674 (22.9) 
TC 90 083 (35.9) 27.5 (4.7) 22 083 (24.5) 




General health    
Excellent  45 665 (18.2) 25.5 (3.5) 5 555 (12.3) 
Good 148 629 (59.2) 27.1 (4.3) 34 832 (23.7) 
Fair 47 272 (18.8) 29.3 (5.3) 18 300 (39.6) 
Poor 8 798 (3.5) 30.8 (6.7) 4 292 (51.0) 
Missing  761 (0.3) 29.2 (5.9) 304 (41.3) 
P¶   <1.0x10-300 <1.0x10-300 
24 
 
† P-value from linear regression.  ‡ Obesity = BMI > 30, and the P-values are from logistic 486 
regression. § adjusted for age and sex.  ¶ further adjusted for types of genotyping array and 15 487 
principal components 488 
  489 
25 
 
Table2. Instrument validation and observational and Mendelian randomisation analyses of depression on body mass index in the UK Biobank.  490 
    All  Women  Men  
     
Association between GRSMDD and depression  OR (95% CI) 1.021 (1.018, 1.023) 1.019 (1.015, 1.023) 1.023 (1.019, 1.028) 
 P 2.1E-45 4.5E-24 6.2E-24 
 r2 (in %) 0.17 0.20 0.18 
Observational association between depression and BMI†     
    Simple model 
Beta (95% CI) 0.19 (0.18, 0.20) 0.25 (0.24, 0.27) 0.10 (0.08, 0.11) 
P 5.0E-215 2.0E-190 2.0E-29 
     
    Adjusted model 
Beta (95% CI) 0.06 (0.05, 0.07) 0.09 (0.07, 0.11) -0.002 (-0.02, 0.01) 
P 5.5E-22 2.1E-25 0.79 
     
Genetic association between depression and BMI     
     
    MR: two-stage least square regression, one sample‡  
  
Beta (95% CI) 0.09 (0.04, 0.13) 0.11 (0.04, 0.18) 0.06 (0.01, 0.11) 
P 0.0001 0.004 0.01 
     
    MR: inverse Variance weighted, two-sample§ 
Beta (95% CI) 0.06 (-0.02, 0.14) NA NA  
P 0.16   
     
    MR: weighted median, two sample§  
Beta (95% CI) 0.06 (-0.00, 0.12) NA NA 
P 0.07   
     
    MR: Egger, two sample§ 
Beta (95% CI) 0.57 (0.04, 1.09) NA NA 
P 0.04   
 Pintercept 0.06   
† An observational association with estimates from linear regression analyses from two models: simple model involved adjustment for age, sex and assessment centre while 491 
the adjusted model included further adjustment for Townsend deprivation index, education, physical activity, sedentary behaviour, vegetable and fruit consumption, 492 
cigarette smoking, alcohol consumption and general health status.   493 
‡ A genetic association with estimates from one-sample MR analyses using the UK Biobank, results from two-stage least squares regression analyses adjusted for age, sex, 494 
assessment centre, type of array, and 15 PCs. 495 
§ A genetic association with estimates from two-sample MR analyses using variant-MDD estimates from Wray et al (Wray et al., 2018), and variant-BMI estimates from UK 496 
Biobank.   497 
r2 indicated the depression variability explained by the GRSMDD. This was calculated by subtracting the r2 value of a model containing only covariates without the GRSMDD, 498 
from the r2 of a full model inclusive of the GRSMDD.   499 
NA not applicable. 500 
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Table 3. Association of the GRSBMI and MC4R variant with BMI in UK Biobank   501 
    Beta SE r2 P P-interaction† 
Total GRSBMI‡ 
All  0.21 0.003 0.013 <1.0x10300 
 
Women 0.22 0.005 0.012 <1.0x10-300 
1.0x10-4 
Men 0.20 0.004 0.015 <1.0x10-300 
       
Neuronal GRSBMI‡ 
All  0.21 0.004 0.009 <1.0x10-300 
 
Women 0.22 0.006 0.009 <1.0x10-300 
1.9x10-3 
Men 0.20 0.005 0.011 <1.0x10-300 
       
Non-neuronal  GRSBMI‡ 
All  0.20 0.006 0.004 1.0x10-285 
 
Women 0.22 0.008 0.004 1.0x10-143 
9.0x10-3 
Men 0.19 0.007 0.004 2.0x10-151 
       
rs6567160 
All  0.05 0.003 0.001 6.1x10-78 
 
Women 0.06 0.004 0.001 7.3x10-44 
1.4x10-2 
Men 0.04 0.004 0.001 1.1x10-35 
† Two-way interaction between sex and genetic variants on BMI.  502 
‡ Associations shown for differences in BMI (SD) per 10 allele increase for the GRSBMI, whereas for rs6567160 503 
association are shown per one allele increase.  504 
r2 indicated the BMI variability explained by the GRSBMI. This was calculated by subtracting the r2 value of a 505 
model containing only covariates without the GRSBMI, from the r2 of a full model inclusive of the GRSBMI.   506 
 507 
  508 
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Table 4. Association between GRSBMI and BMI among individuals with and without depression 509 
  
  
P-interaction† P-interaction‡ Depression case Control 
Beta SE r2 P Beta SE r2 P 
Total GRSBMI§ 
All  0.24 0.0051 0.015 2.1x10-123 0.20 0.0051 0.013 <1.0x10-300 9.1x10-4 
 
Women 0.25 0.0051 0.015 8.0x10-77 0.22 0.0051 0.012 <1.0x10-300 0.01 
0.35 Men 0.21 0.0051 0.015 2.3x10
-50 0.19 0.0051 0.015 <1.0x10-300 0.02 
            
Neuronal GRSBMI§ 
All  0.24 0.0051 0.011 4.0x10-93 0.21 0.0051 0.01 <1.0x10-300 0.006 
 
Women 0.26 0.0051 0.011 1.1x10-57 0.22 0.0051 0.009 1.1x10-231 0.03 
0.32 Men 0.22 0.0051 0.011 1.2x10
-38 0.20 0.0051 0.011 <1.0x10-300 0.31 
            
Non-neuronal GRSBMI§ 
All  0.23 0.0051 0.004 6.1x10-34 0.20 0.0051 0.004 5.4x10-223 0.08 
 
Women 0.25 0.0102 0.004 3.6x10-22 0.22 0.0102 0.004 1.1x10-104 0.21 
0.67 Men 0.20 0.0102 0.004 1.0x10
-13 0.19 0.0102 0.004 2.2x10-123 0.62 
† Two-way interaction between GRSBMI and depression on BMI.  510 
‡ Three-way interaction among GRSBMI, sex and depression on BMI. 511 




Figure legends  514 
Figure 1. GRSBMI and BMI in UK Biobank (The histogram shows the distribution of BMI 515 
GRS, with the line indicating the predicted relationship between GRSBMI and BMI (Kg/m
2)). 516 
Figure 2. Association between neuronal GRSBMI and BMI among individuals with, and 517 
without depression (The lines show the changes in BMI per change in neuronal GRSBMI, 518 
where the dotted line represents depression case group, and the solid line represents control 519 
group).   520 
Figure 3. Association between rs6567160 variant (near MC4R gene) and BMI among 521 
individuals with and without depression (Control (main) and case (main) indicators are 522 
derived from the main depression outcome, self-report and hospital episode statistic 523 
combined. Control (HES data) and case (HES data) are defined using depression diagnosis 524 
history from Hospital episode statistics data).    525 
 526 
